We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$670M
1-Year Est. Return
34.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+34.04%
3 Year Est. Return
+107.53%
5 Year Est. Return
+130.35%
10 Year Est. Return
+379.12%
AUM
$422M
AUM Growth
+$39.5M
(+10%)
Cap. Flow
+$5.79M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
240
New
12
Increased
81
Reduced
118
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.19M |
| 2 |
UnitedHealth
UNH
|
+$3.72M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97M |
| 4 |
Dick's Sporting Goods
DKS
|
+$2.42M |
| 5 |
Air Products & Chemicals
APD
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.51M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$1.04M |
| 3 |
Medtronic
MDT
|
+$945K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$672K |
| 5 |
Corning
GLW
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.31% |
| 2 | Industrials | 12.36% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Core MSCI EAFE ETF
IEFA
$196B
| $936K | 0.22% |
13,309
+316
| +2% | +$20.8K |
|
77
Cintas
CTAS
$79.8B
| $930K | 0.22% |
6,176
-476
| -7% | -$63.8K |
|
78
Booking.com
BKNG
$160B
| $926K | 0.22% |
6,525
+100
| +2% | +$12.5K |
|
79
Cadence Design Systems
CDNS
$89.6B
| $871K | 0.21% |
3,199
-247
| -7% | -$63.6K |
|
80
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
| $857K | 0.2% |
8,172
+248
| +3% | +$24.3K |
|
81
Amgen
AMGN
$224B
| $843K | 0.2% |
2,928
+12
| +0.4% | +$3.27K |
|
82
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$334M
| $835K | 0.2% |
17,553
-6,025
| -26% | -$258K |
|
83
McKesson
MCK
$101B
| $825K | 0.2% |
1,781
-186
| -9% | -$84.6K |
|
84
Fair Isaac
FICO
$23.6B
| $807K | 0.19% |
693
-80
| -10% | -$80.5K |
|
85
Salesforce
CRM
$161B
| $804K | 0.19% |
3,055
+57
| +2% | +$12.9K |
|
86
ON Semiconductor
ON
$32B
| $796K | 0.19% |
9,524
-1,467
| -13% | -$115K |
|
87
PPG Industries
PPG
$25.4B
| $774K | 0.18% |
5,174
-515
| -9% | -$69.7K |
|
88
Alerian MLP ETF
AMLP
$13.2B
| $762K | 0.18% |
17,920
+860
| +5% | +$36.5K |
|
89
AutoZone
AZO
$49.5B
| $745K | 0.18% |
288
-36
| -11% | -$93.4K |
|
90
Palo Alto Networks
PANW
$311B
| $739K | 0.18% |
5,012
-438
| -8% | -$58.6K |
|
91
Vanguard Total Bond Market
BND
$161B
| $736K | 0.17% |
+10,011
| New | +$707K |
|
92
Adobe
ADBE
$105B
| $732K | 0.17% |
1,227
+40
| +3% | +$23.1K |
|
93
Abbott
ABT
$192B
| $727K | 0.17% |
6,608
-184
| -3% | -$18.4K |
|
94
Cboe Global Markets
CBOE
$30.9B
| $719K | 0.17% |
4,024
-508
| -11% | -$87.1K |
|
95
PG&E
PCG
$39.2B
| $716K | 0.17% |
39,738
-4,096
| -9% | -$69.2K |
|
96
O'Reilly Automotive
ORLY
$73.7B
| $695K | 0.16% |
10,965
-1,365
| -11% | -$86.3K |
|
97
Cardinal Health
CAH
$54.5B
| $692K | 0.16% |
6,862
-805
| -10% | -$79.9K |
|
98
Equifax
EFX
$21.3B
| $689K | 0.16% |
+2,788
| New | +$565K |
|
99
Procter & Gamble
PG
$336B
| $684K | 0.16% |
4,671
+151
| +3% | +$22.4K |
|
100
Global X US Infrastructure Development ETF
PAVE
$14.3B
| $676K | 0.16% |
19,622
+1,130
| +6% | +$35.2K |
|
Similar funds
TAP
CCM
BCP
AVM
FAM
MCO
CCG
PAI
Strategy Asset Managers's Q4 2023 Portfolio in Review
As of Q4 2023, Strategy Asset Managers held 240 positions worth $422M, up 10% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Strategy Asset Managers's Q4 2023 filing shows 12 new, 81 increased, 118 reduced and 12 closed positions. Its largest new stake was Dick's Sporting Goods: 19,908 shares worth $2.93M. The largest sale was Pfizer, an estimated $5.51M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Strategy Asset Managers's largest Q4 2023 buy was Dick's Sporting Goods: 19,908 shares worth $2.93M.
- Strategy Asset Managers added most to Eli Lilly in Q4 2023, an estimated $5.19M increase.
- Strategy Asset Managers's biggest Q4 2023 reduction was Pfizer, cutting an estimated $5.51M.
- Strategy Asset Managers fully exited iShares US Medical Devices ETF in Q4 2023, selling an estimated $1.04M.
- Strategy Asset Managers's ten largest holdings make up 30% of its $422M portfolio in Q4 2023.
- Strategy Asset Managers opened 12 new positions and closed 12 in Q4 2023.
- Strategy Asset Managers's portfolio value rose 10% quarter-over-quarter to $422M.
Based on Strategy Asset Managers's 13F filing for Q4 2023, filed 12 Feb 2024.